Catheter Precision (VTAK) EBITDA Margin (2017 - 2026)
Catheter Precision's (VTAK) quarterly EBITDA Margin came in at 388.13% in Q2 2026, up 182225.0% year-over-year from N/an in Q2 2025, and up 27.67% quarter-over-quarter from 536.57% in Q1 2026.
Powered by 
Analysis
Catheter Precision (VTAK) EBITDA Margin (2017 - 2026) Analysis & Trends
Catheter Precision (VTAK) has reported EBITDA Margin for 10 consecutive years, with 388.13% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 182225.0% year-over-year to 388.13% in Q2 2026; TTM through Jun 2026 was 1000.26%, a 136157.0% increase from a year earlier, with the FY2025 full-year figure at 2581.56%, up 9534.0% from the prior year.
- EBITDA Margin was 388.13% for Q2 2026 at Catheter Precision, up from 536.57% in the prior quarter.
- Over five years, EBITDA Margin peaked at 388.13% in Q2 2026 and troughed at 169200.0% in Q2 2022.
- A 5-year average of 21341.62% and a median of 2710.75% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin tumbled 16847940 bps in 2022 and surged 16262917 bps in 2023, its largest moves.
- Over 5 years, EBITDA Margin stood at 169200.0% in 2022, then jumped by 99 bps to 2028.91% in 2023, then slipped by 1 bps to 2047.65% in 2024, then plunged by 102 bps to 4143.28% in 2025, then surged by 91 bps to 388.13% in 2026.
- The last three EBITDA Margin figures came in at 388.13% (Q2 2026), 536.57% (Q1 2026), and 4143.28% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 19.15% |
| 10 | Catheter Precision | 553,488.01 | -1.71 Mn | 98,000.00 | -388.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -388.13% |
| Mar 31, 2026 | -536.57% |
| Dec 31, 2025 | -4,143.28% |
| Sep 30, 2025 | -1,336.73% |
| Jun 30, 2025 | -2,210.38% |
| Mar 31, 2025 | -2,500.00% |
| Dec 31, 2024 | -2,047.65% |
| Sep 30, 2024 | -2,978.13% |
| Jun 30, 2024 | -2,921.51% |
| Mar 31, 2024 | -3,190.24% |
| Dec 31, 2023 | -2,028.91% |
| Sep 30, 2023 | -2,052.63% |
| Jun 30, 2023 | -6,570.83% |
| Mar 31, 2023 | -78,216.47% |
| Jun 30, 2022 | -169,200.00% |
| Mar 31, 2022 | -61,144.44% |
| Dec 31, 2021 | -165,280.00% |
| Sep 30, 2021 | -147,880.00% |
| Jun 30, 2021 | -720.60% |
| Mar 31, 2021 | -171,750.00% |